IWC
ALXN

Integrated Wealth Concepts’s Alexion Pharmaceuticals ALXN Stock Holding History

Integrated Wealth Concepts’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,026
Closed -$616K – 849
2021
Q1 		$616K Buy
4,026
+118
+3% +$18.3K 0.03% 424
2020
Q4 		$611K Buy
3,908
+699
+22% +$89.8K 0.03% 367
2020
Q3 		$367K Buy
3,209
+586
+22% +$63.2K 0.02% 409
2020
Q2 		$294K Buy
+2,623
New +$278K 0.02% 407
2020
Q1 		– Sell
-2,367
Closed -$256K – 492
2019
Q4 		$256K Buy
2,367
+141
+6% +$15.1K 0.02% 399
2019
Q3 		$218K Buy
2,226
+457
+26% +$51.5K 0.02% 392
2019
Q2 		$232K Buy
1,769
+118
+7% +$15.2K 0.03% 331
2019
Q1 		$223K Buy
+1,651
New +$205K 0.04% 296
2018
Q4 		– Sell
-1,497
Closed -$205K – 293
2018
Q3 		$205K Buy
+1,497
New +$188K 0.06% 237

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.3B AUM 67.69% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Integrated Wealth Concepts's ALXN Position: Q2 2021 in Review

Integrated Wealth Concepts sold out of Alexion Pharmaceuticals (ALXN) in Q2 2021, closing a stake of 4,026 shares — an estimated $616K sold.

Integrated Wealth Concepts first reported a position in ALXN in Q3 2018 and held it in 9 quarters. The position peaked at $616K in Q1 2021. 710 funds tracked by Wall St. Rank hold ALXN as of Q2 2021.

  • Integrated Wealth Concepts reported no remaining Alexion Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Integrated Wealth Concepts sold 4,026 Alexion Pharmaceuticals shares in Q2 2021, an estimated $616K.
  • Integrated Wealth Concepts first reported a position in Alexion Pharmaceuticals in Q3 2018 and held it in 9 quarters.
  • Integrated Wealth Concepts's Alexion Pharmaceuticals position peaked at $616K in Q1 2021.
  • 710 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2021.

Based on Integrated Wealth Concepts's 13F filing for Q2 2021, filed 13 Aug 2021.